Wendy Quinn | 19/08/2022
by Wendy Quinn, President of the Canadian Hemophilia Society This summer I had the great privilege of finally attending the infamous Camp Blast – the Newfoundland and Labrador’s version...
David Page | 15/08/2022
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022 to March 31, 2025....
CHS/SCH | 18/07/2022
In an effort to bring young volunteers into the CHS, and in recognition that a sound education is of utmost importance particularly for those who might not be able...
CHS/SCH | 04/07/2022
Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best represent people with hemophilia...